Gonorrhea: Page 2

New world order for STD tests | Red flags on CLIA-waived products | FDA's burst of preholiday actions

Dear LabPulse Member,

May 27, 2019

STD test market grows with incidence, new tech

Not that long ago, rates of gonorrhea infection were at historically low levels, and elimination of syphilis was a reasonable goal. The diagnostics industry was able to highlight how advances in STD detection and prevention brought increased rates of detection and treatment.

May 27, 2019

FDA clears 1st extragenital STD tests

The tests are designed to detect the presence of the bacteria Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) with extragenital specimens acquired via the throat and rectum. Previously, the tests were cleared only for use with urine, vaginal, and endocervical samples.

May 22, 2019

Most Popular

Genetic causes identified for three rare diseases

Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease

SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests

Duke University researchers discover biomarkers may identify early pancreatic cancer risk

Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics

Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition